| Application no. and date | 07819133.5 (espacenet) (Federated) (European Patent Register), 20071019 | | Patent/reg. no. and date | DK/EP 2099453, 20170906 | | Publication date | 20090916 | | Priority no. and date | DE 102006051625, 20061102 | | EP pub. no. and date |
EP 2099453 20090916 | | Effective date | | | Applicant/owner | Bayer Intellectual Property GmbH, Alfred-Nobel-Str. 50
40789 Monheim am Rhein, DE | | Applicant ref. no. | BBS BHC061183PCT-EP | | Inventor | PERZBORN, Elisabeth, Am Tescher Busch 13
42327 Wuppertal, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4365 (2006.01) , A61K 31/52 (2006.01) , A61K 31/5377 (2006.01) , A61K 31/60 (2006.01) , A61P 43/00 (2006.01) , A61P 7/02 (2006.01) , A61P 9/04 (2006.01) , A61P 9/10 (2006.01) | | Title | Kombinationsterapi med substituerede oxazolidinoner | | Int. application no. | EP2007009068 | | Int. publication no. | WO2008052671 | | Related patent (certificate) | CA 2018 00009 | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
